Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.

× No keyword cloud information.

22 in total

1. Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC-MS/MS.

Authors: Liusheng Huang; Patricia Lizak; Francesca Aweeka; Janel Long-Boyle
Journal: J Pharm Biomed Anal Date: 2013-08-23 Impact factor: 3.935

Review 2. Cellular and clinical pharmacology of fludarabine.

Authors: Varsha Gandhi; William Plunkett
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

Review 3. Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

Authors: J C Adkins; D H Peters; A Markham
Journal: Drugs Date: 1997-06 Impact factor: 9.546

4. Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycin.

Authors: P P Major; R P Agarwal; D W Kufe
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

Review 5. Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.

Authors: S R Ross; D McTavish; D Faulds
Journal: Drugs Date: 1993-05 Impact factor: 9.546

6. Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology.

Authors: V Gandhi; L E Robertson; M J Keating; W Plunkett
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

7. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.

Authors: D A Carson; D B Wasson; J Kaye; B Ullman; D W Martin; R K Robins; J A Montgomery
Journal: Proc Natl Acad Sci U S A Date: 1980-11 Impact factor: 11.205

Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.